Enhanced Angiogenic and Cardiomyocyte Differentiation Capacity of Epigenetically Reprogrammed Mouse and Human Endothelial Progenitor Cells Augments their Efficacy for Ischemic Myocardial Repair

RATIONALE: While Bone-marrow endothelial progenitor cell based therapies (BM-EPC) improve the symptoms in patients with ischemic heart disease their limited plasticity and decreased function in patients with existing heart disease limits the full benefit of EPC therapy for cardiac regenerative medic...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Thal, Melissa A., Krishnamurthy, Prasanna, Mackie, Alexander R., Hoxha, Eneda, Lambers, Erin, Verma, Suresh, Ramirez, Veronica, Qin, Gangjian, Losordo, Douglas W., Kishore, Raj
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3406600/
https://ncbi.nlm.nih.gov/pubmed/22589372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCRESAHA.112.270462
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky